Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jason A. Leverone Insider Profile
11 Followers
Jason A. Leverone, CFO at Viridian Therapeutics, holds 16.33K shares in OnKure Therapeutics (Ticker: OKUR), holds 48.83K shares in Viridian Therapeutics (Ticker: VRDN).
Jason A. Leverone has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jason A. Leverone holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jason A. Leverone
Jason A. Leverone's Trading History
Viridian Therapeutics
Mar 17, 2020
CFO
Uninformative Buy
6.41K
$958.02K
OnKure Therapeutics
Oct 08, 2024
Chief Financial Officer
Uninformative Buy
―
$261.13K
List of latest transactions for each holding click on a transaction to see Jason A. Leverone's performance on stock
You May Also Like
Jason A. Leverone insider profile FAQ
What is the percentage of profitable transactions made by Jason A. Leverone?
The percentage of profitable transactions made by Jason A. Leverone is ―.
What is the average return per transaction made by Jason A. Leverone?
The average return per transaction made by Jason A. Leverone is ―.
What stocks does Jason A. Leverone hold?
Jason A. Leverone holds: VRDN, OKUR stocks.
What was Jason A. Leverone’s latest transaction?
Jason A. Leverone latest transaction was an Uninformative Buy of ―.
What was Jason A. Leverone's most profitable transaction?
Jason A. Leverone’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jason A. Leverone's role in Viridian Therapeutics?
Jason A. Leverone's role in Viridian Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.